These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 834247)

  • 1. Suppression of noradrenaline synthesis in sympathetic nerves by carbidopa, an inhibitor of peripheral dopa decarboxylase.
    Wurtman RJ; Watkins CJ
    Nature; 1977 Jan; 265(5589):79-80. PubMed ID: 834247
    [No Abstract]   [Full Text] [Related]  

  • 2. Transamination is a major pathway of L-dopa metabolism following peripheral decarboxylase inhibition.
    Sandler M; Johnson RD; Ruthven CR; Reid JL; Calne DB
    Nature; 1974 Feb; 247(5440):364-6. PubMed ID: 4817854
    [No Abstract]   [Full Text] [Related]  

  • 3. Aterial blood pressure in dogs: effects of m-tyrosine alone or in combination with inhibitors of aromatic amino acid decarboxylase; relative hypotensive potencies of L-dopa, DL-m-tyrosine, and L-m-tyrosine.
    Minsker DH; Stokes AL
    Experientia; 1974 Sep; 30(9):1051-3. PubMed ID: 4412113
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of the activation of alpha-adrenoreceptors on the synthesis and release of noradrenaline by peripheral adrenergic nerves in vivo.
    Rochette L; Beley A; Bralet J
    J Neural Transm; 1976; 39(1-2):21-32. PubMed ID: 978194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbidopa attenuation of L-DOPA emesis in dogs: evidence for a cerebral site of action outside the blood-brain barrier.
    Lotti VJ; Clark C
    Eur J Pharmacol; 1974 Mar; 25(3):322-5. PubMed ID: 4827858
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of VB6 on L-DOPA decarboxylase activity in the organs of rats given peripheral L-DOPA decarboxylase inhibitors (author's transl)].
    Yoshimine N; Kuzuya F; Mori K; Sakamoto N
    Nihon Ronen Igakkai Zasshi; 1978 Nov; 15(6):566-73. PubMed ID: 732010
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison of the effects of decarboxylase inhibitors on L-dopa-induced circling behavior and the conversion of dopa to dopamine in the brain.
    Goodale DB; Moore KE
    Life Sci; 1976 Sep; 19(5):701-6. PubMed ID: 957902
    [No Abstract]   [Full Text] [Related]  

  • 8. L-DOPA: centrally mediated emission of seminal fluid in male rats.
    Friedman E; Gershon S
    Life Sci I; 1972 May; 11(9):435-40. PubMed ID: 4656863
    [No Abstract]   [Full Text] [Related]  

  • 9. Localization of the site of the central sympatho-inhibitory action of 1-Dopa in dogs and cats.
    Schmitt H; Fenard S
    Eur J Pharmacol; 1973 May; 22(2):212-6. PubMed ID: 4715222
    [No Abstract]   [Full Text] [Related]  

  • 10. Further studies on the behavioural and biochemical interaction between caffeine and L-DOPA.
    Strömberg U; Waldeck B
    J Neural Transm; 1973; 34(4):241-52. PubMed ID: 4359657
    [No Abstract]   [Full Text] [Related]  

  • 11. L-3,4-dihydroxyphenylalanine-induced of norepinephrine from the rat heart.
    Landsberg L
    Biochem Pharmacol; 1971 Dec; 20(12):3542-7. PubMed ID: 5132898
    [No Abstract]   [Full Text] [Related]  

  • 12. Involvement of dopamine in development of hypertension in spontaneously hypertensive rat: effect of carbidopa, inhibitor of peripheral dopa decarboxylase.
    Yoshimura M; Kambara S; Takahashi H; Okabayashi H; Ijichi H
    Clin Exp Hypertens A; 1987; 9(10):1585-99. PubMed ID: 3677444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of decarboxylase and levels of dopa and 3-O-methyldopa: a comparative study of benserazide versus carbidopa in rodents and of Madopar standard versus Madopar HBS in volunteers.
    Da Prada M; Kettler R; Zürcher G; Schaffner R; Haefely WE
    Eur Neurol; 1987; 27 Suppl 1():9-20. PubMed ID: 3123242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of noradrenaline from 3,4-dihydroxyphenylalanine (DOPA) and dopamine in adrenergic nerves of mouse atrium--effect of reserpine, monoamine oxidase and tyrosine hydroxylase inhibition.
    Jonsson G; Sachs C
    Acta Physiol Scand; 1970 Nov; 80(3):307-22. PubMed ID: 5486459
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of a decarboxylase inhibitor on the Dopa and 5-HTP induced changes in the locomotor-like discharge pattern of rabbit hind limb nerves.
    Viala D; Buser P
    Psychopharmacologia; 1974; 40(3):225-33. PubMed ID: 4548539
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacological studies on a possible role of central noradrenaline neurons in respiratory control.
    Bolme P; Fuxe K
    J Pharm Pharmacol; 1973 Apr; 25(4):351-2. PubMed ID: 4146697
    [No Abstract]   [Full Text] [Related]  

  • 17. Excretion and metabolism of dopa and dopamine by isolated perfused rat kidney.
    Suzuki H; Nakane H; Kawamura M; Yoshizawa M; Takeshita E; Saruta T
    Am J Physiol; 1984 Sep; 247(3 Pt 1):E285-90. PubMed ID: 6433718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothalamic secretion of dopamine after inhibition of aromatic L-amino acid decarboxylase activity.
    Reymond MJ; Porter JC
    Endocrinology; 1982 Oct; 111(4):1051-6. PubMed ID: 6811255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decarboxylation of DL-2,4-dihydroxyphenylalanine (2,4-DOPA) to 2,4-dihydroxyphenylethylamine in mouse striatal slices.
    Orosz D; Cohen G
    Eur J Pharmacol; 1987 Apr; 136(3):441-4. PubMed ID: 3111867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central decarboxylation and uptake of L-DOPA.
    Andén NE; Engel J; Rubenson A
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 273(1):11-26. PubMed ID: 4260798
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.